Ocugen Inc. (NASDAQ: OCGN) Sponsored Survey Reveals That Parents Want Alternative COVID-19 Vaccines For Children 

A survey conducted on behalf of Ocugen Inc. (NASDAQ: OCGN) by The Harris Poll on February 3-7, 2022, revealed that almost a year after the first COVID-19 vaccination in the US, over 545 million doses had been administered, but most of the Americans want more vaccines alternatives to choose from.

Survey indicates more Americans want an alternative to available vaccine s

Out of the 2,000 US adults surveyed, 73%  indicated that they would want to have access to more vaccine alternatives developed from more conventional methods like mumps, polio, chickenpox, diphtheria, and chickenpox, which have been used in children and adults for a long. While the debate over childhood vaccines continues, the study found that a 38percent of parents with kids under five years say they will not allow their children to get the COVID-19 vaccine using current options if/when they are available.

Ocugen CEO and Co-Founder, Dr. Shankar Musunuri, said, “With the nation’s attention focused on the health and safety of children under 5 in the face of the pandemic, it’s important that we all keep in mind that nearly 2 in 5 parents with kids 5 and under say they will not get their kids vaccinated with the available vaccines. All safe and effective options should be considered to manage the pandemic.”

41% of parents could allow children below 18 to get vaccinated 

If there was a new vaccine more effective against various versions and emerging variants of concern, 41% of parents with children below the 18 years old yet to get vaccinated will get them vaccinated of COVID-19 once the vaccines become available.   Seventy percent of Americans agree that children should be vaccinated against COVID-19. Also, another  75 percent of vaccinated Individuals agree that they will obtain a COVID-19 booster shot every six months if it is suggested.

The Harris Poll conducted an online survey of 2,015 persons ages 18 and up in the United States on behalf of the company. Because this online poll is not based on a random sample, no random selection error estimate can be derived.